Pathogen characteristics reveal novel antibacterial approaches for interstitial lung disease

In conclusion, aminoglycosides and carbapenems may be selected as a priority for secondary infection to control ILD progression. Meanwhile, the use of anti-MRSA/MRCNS drugs may be considered for Staphylococcus infection.
Source: Pulmonary Pharmacology and Therapeutics - Category: Respiratory Medicine Source Type: research